ArticleHarm reduction journal2026
Peer-led drug checking in Chile: a case study of the country's first harm reduction service at electronic music events.
Article in Harm reduction journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe health risks for people who use drugs (PWUD) in Chile are exacerbated by evolving drug markets, unpredictable supplies, and the limited availability of harm reduction services. Community-based drug-checking programs have shown effectiveness in reducing some of these risks; however, regional evidence remains limited. CASE PRESENTATION: In 2024, Reduciendo Daño (RD), a Chilean non-profit organization, conducted a peer-led drug-checking program, attending 22 electronic music events in Santiago. Event attendees interested in testing their substances placed small samples on the designated testing surface, after which staff conducted rapid colorimetric analysis and recorded the samples' characteristics and test results. RD staff analyzed 992 samples; most of the samples, according to the event attendees, were MDMA (78%), followed by ketamine (9%), cocaine (6%), tusi (5%), and other substances (2%). The analysis showed that more than 80% of the samples purported MDMA contained MDMA. 10% of the samples expected to be MDMA contained MDA instead, and the most common adulterant in MDMA samples was methamphetamine (8%). Cocaine was found in all samples expected to be cocaine (n = 62), but more than two-thirds of the samples (71%) were adulterated. Tusi samples (n = 48) were heterogeneous. Ketamine was the only substance detected in 42% of all the ketamine samples: 33% had a combination of ketamine and MDMA, 15% contained ketamine plus other substances, and 10% had no detectable substances. Excluding tusi, about 70% of the samples matched the attendees' expectations, 14% were adulterated, and 16% lacked the expected drug.
conclusionsThis peer-led harm reduction intervention provided timely and practical information to PWUD. The findings indicate that MDMA was the most common substance tested among attendees of electronic music events, that tusi showed considerable variability in its composition, and that cocaine was frequently adulterated with other substances. Together, these results underscore the need to strengthen and expand harm reduction initiatives in Chile, such as community-based drug checking programs, that provide information about substances and education on safer drug use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.